Beizray

Active Ingredient(s): Docetaxel
FDA Approved: * October 23, 2024
Pharm Company: * ZHUHAI
Category: Cancer

Docetaxel (DTX or DXL), sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer.[4] This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer.[5] It may be used by itself or along with other chemotherapy medication.[4] It is given by slow injection into a vein.[4] Common side effects include hair loss, cytopenia... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

BeizrayBeizray Intravenous Kit
NDC: 83513-010
Labeler:
Zhuhai Beihai Biotech Co., Ltd.

Related Brands

Drugs with the same active ingredients